Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903403 · ClinicalTrials.gov registry record · NA
Comparing Front-of-package Nutrient Labels
A NA study of Dietary Behavior and Nutrition Knowledge, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 15,582
- Enrollment target
- 1
- Study location
NCT06903403: Completed NA study of Dietary Behavior and Nutrition Knowledge, sponsored by University of California, Davis.
NCT06903403 is a NA study of Dietary Behavior and Nutrition Knowledge that has completed, run by University of California, Davis. The registered enrollment target is 15,582 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1011% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06903403, a NA study of Dietary Behavior and Nutrition Knowledge, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 15,582 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare front-of-package labels to a no-label control and to one another: 1.) FDA's Nutrition Info with %DV, 2.) Nutrition Info with red "high", 3.) FDA's High In, 4.) multiple High In labels-one for each nutrient and 5.) a no-label control. Primary outcomes include 1.) correct identification of foods and beverages with the healthiest and least healthy overall nutrient profiles, 2.) perceived healthfulness of products low in two nutrients of concern, and 3.) correct identification of foods and beverages as high in saturated fat, sodium, and added sugars.
Primary Outcome
Participants will view 4 series of 3 products on the same screen, with each product having a nutrient profile. They will be instructed, "Choose the food \[beverage\] that has the healthiest overall nutrient profile. Consider saturated fat, sodium, and added sugars." Outcome for each series will be dichotomized (1 = correct, 0 = incorrect), and the multiple outcomes will be used in mixed effects Poisson regression with robust standard errors.
Conditions Studied
Interventions
- OTHER Front-of-package label
Study Locations (1)
California
- University of California, Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,582 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2025-04-25 |
| Phase | NA |
What the finished NCT06903403 record still lists
NCT06903403 is an interventional study that assigns participants to a tested intervention. Its 15,582 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1011% higher).
The record links to 3 conditions, with Dietary Behavior appearing as the primary indexed condition, and to 1 intervention - of which Front-of-package label is the first listed.
NCT06903403 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06903403 about?
NCT06903403 is a clinical study titled "Comparing Front-of-package Nutrient Labels". The goal of this study is to compare front-of-package labels to a no-label control and to one another: 1.) FDA's Nutrition Info with %DV, 2.) Nutrition Info with red "high", 3.) FDA's High In, 4.) multiple High In labels-one for each nutrient and 5.) a no-label control. Primary outcomes include 1.) ...
What is the current status of trial NCT06903403?
This trial is currently completed. It is a NA study. The enrollment target is 15,582 participants. The study started on 2025-04-01. Estimated completion is 2025-04-25.
What conditions does trial NCT06903403 study?
This clinical trial studies the following conditions: Dietary Behavior, Nutrition Knowledge, Perceptions.
What interventions are being tested in trial NCT06903403?
The interventions under investigation include: Front-of-package label (OTHER).
Who is sponsoring clinical trial NCT06903403?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903403 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dietary Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06903403's enrollment target sits among peer trials
15,582 13th of 2000 higher than 1,988 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05447806 · 15,732 participants · NA
Diabetes Clinical Decision Support
- NCT01737528 · 16,000 participants
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
- NCT06380114 · 16,000 participants · NA
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
- NCT07000357 · 15,100 participants · Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI